VolitionRX (VNRX) COO Michel gave up 12,333 shares at $0.65 to cover taxes or an exercise price
Insider transactions reported
Gaetan Michel (Chief Operating Officer at VolitionRX Limited, VNRX) reported that they gave up 12,333 shares at $0.65 to cover taxes or an exercise price on Oct 4, 2025. After these transactions the filing shows 256,746 shares held directly.
- Reporting person
- Michel Gaetan
- Role
- Chief Operating Officer
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Oct 4, 2025 | Shares withheld for taxes or exercise price (F) | Common Stock1 | -12,333 | $0.65 | $7,992 | 256,746 direct |
Holdings before and after
- Common Stock: 269,079 to 256,746 direct
Footnotes from the filing
- 1. Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 24,666 restricted stock units. No shares were sold by the reporting person or VolitionRx in such transaction.
Transaction codes in this filing
- Shares withheld for taxes or exercise price:
- Code F marks shares handed back or withheld to pay taxes or an exercise price. No sale happens in the market.
FAQ
What did Michel report in this VNRX Form 4?
Gaetan Michel (Chief Operating Officer at VolitionRX Limited, VNRX) reported that they gave up 12,333 shares at $0.65 to cover taxes or an exercise price on Oct 4, 2025. After these transactions the filing shows 256,746 shares held directly.
How many VNRX shares does Michel hold after this filing?
The filing shows 256,746 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code F mean on an SEC Form 4?
Code F marks shares handed back or withheld to pay taxes or an exercise price. No sale happens in the market.
Historical context for VNRX
Earlier insider filings at VNRX
- Oct 7, 2025GC - Volition Diagnostics Plummer Nicholas covered exercise/tax liability with 8,146 shares, decreasing direct ownership by 4% to 199,731 units (SEC Form 4)
- Oct 7, 2025Chief Scientific Officer Micallef Jacob Vincent covered exercise/tax liability with 5,850 shares, decreasing direct ownership by 1% to 393,089 units (SEC Form 4)
- Sep 30, 2025CEO - Volition Veterinary Butera Salvatore Thomas covered exercise/tax liability with 5,230 shares, decreasing direct ownership by 2% to 332,285 units (SEC Form 4)
- Sep 30, 2025Secretary Rootsaert Rodney Gerard covered exercise/tax liability with 4,158 shares, decreasing direct ownership by 3% to 145,075 units (SEC Form 4)
- Sep 30, 2025Chief Scientific Officer Micallef Jacob Vincent covered exercise/tax liability with 5,568 shares, decreasing direct ownership by 1% to 398,939 units (SEC Form 4)
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Listed since
- 2015
Follow VNRX and get a push notification the moment its next story breaks.